{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:56:54Z","timestamp":1778583414548,"version":"3.51.4"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019492","name":"National Natural Science Foundation of China-China Academy of General Technology Joint Fund for Basic Research","doi-asserted-by":"publisher","award":["82101175"],"award-info":[{"award-number":["82101175"]}],"id":[{"id":"10.13039\/501100019492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To compare the myopic progression in children treated with 0. 01% atropine and those who discontinued atropine during the 2022-home quarantine in Shanghai.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective study, children aged 6\u201313 years with follow-up visits before (between January 2022 and February 2022) and after the lockdown (between July 2022 and August 2022) were included. Cycloplegic refraction and axial length (AL) were measured at both visits. The atropine group had continuous medication during the lockdown while the control group discontinued. The 0.01% atropine eyedrops were administered daily before bedtime. The types of spectacle lens were recorded: single vision (SV) spectacles or defocus incorporated multiple segments lenses (DIMS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 41 children (81 eyes) in the atropine group and 32 children (64 eyes) in the control group were enrolled. No significant difference was found in the demographic characteristics, spherical diopter, spherical equivalent (SE), AL, and follow-up time between the two groups before the lockdown in 2022 (all <jats:italic>p<\/jats:italic> &amp;gt; 0.1). After the home confinement, a greater myopia progression was observed in the control group (\u22120.46 \u00b1 0.42 D) compared to atropine group (\u22120.26 \u00b1 0.37 D; <jats:italic>p<\/jats:italic> = 0.0023). Axial elongation was also longer in the control group than that in children sustained with atropine (0.21 \u00b1 0.17 vs. 0.13 \u00b1 0.15 mm, <jats:italic>p<\/jats:italic> = 0.0035). Moreover, there was no significant change of spherical diopter and SE during lockdown in the atropine + DIMS combined subgroup (0.03 \u00b1 0.033 D for spherical diopter, <jats:italic>p<\/jats:italic> = 0.7261 and 0.08 \u00b1 0.27 D for SE, <jats:italic>p<\/jats:italic> = 0.2042, respectively). However, significant myopic shift was observed in the atropine + SV subgroup during the quarantine time (\u22120.31 \u00b1 0.39 D for SE and 0.15 \u00b1 0.16 mm for AL, both <jats:italic>p<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Children treated with 0.01% atropine had slower myopia progression during the lockdown period in Shanghai compared with children discontinued. Moreover, the effect of atropine on myopic prevention can be strengthened with DIMS lenses.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1074272","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T07:49:37Z","timestamp":1674719377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of atropine 0.01% on myopia control in children aged 6\u201313 years during the 2022 lockdown in Shanghai"],"prefix":"10.3389","volume":"11","author":[{"given":"Manrong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1442-9071.2010.02470.x","article-title":"Change in vision disorders among Hong Kong preschoolers in 10 years","volume":"39","author":"Fan","year":"2011","journal-title":"Clin Exp Ophthalmol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/opo.12305","article-title":"Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children","volume":"36","author":"Chua","year":"2016","journal-title":"Ophthalmic Physiol Opt."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","article-title":"Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort","volume":"138","author":"Hu","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319306.","article-title":"Interventions recommended for myopia prevention and control among children and adolescents in China: a systematic review","author":"Zhu","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.62.10.37","article-title":"COVID-19 home quarantine accelerated the progression of myopia in children aged 7 to 12 years in China","volume":"62","author":"Ma","year":"2021","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"720514","DOI":"10.3389\/fpubh.2021.720514","article-title":"The impact of study-at-home during the COVID-19 pandemic on myopia progression in Chinese children","volume":"9","author":"Ma","year":"2021","journal-title":"Front Public Health."},{"key":"B9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/ijo.IJO_1721_21","article-title":"Impact of online classes and home confinement on myopia progression in children during COVID-19 pandemic: digital eye strain among kids (DESK) study 4","volume":"70","author":"Mohan","year":"2022","journal-title":"Indian J Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41433-021-01655-2","article-title":"The effect of home education on myopia progression in children during the COVID-19 pandemic","volume":"36","author":"Aslan","year":"2022","journal-title":"Eye."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaophthalmol.2021.3563","article-title":"Rates of myopia development in young Chinese schoolchildren during the outbreak of COVID-19","volume":"139","author":"Hu","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/S0140-6736(22)00838-8","article-title":"Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic","volume":"399","author":"Zhang","year":"2022","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fphar.2020.01081","article-title":"Analysis of factors that may affect the effect of atropine 001% on myopia control","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 005%, 0025%, and 001% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis","volume":"129","author":"Ha","year":"2022","journal-title":"Ophthalmology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101475","DOI":"10.1016\/j.clae.2021.101475","article-title":"Decreased effectiveness of 001% atropine treatment for myopia control during prolonged COVID-19 lockdowns","volume":"45","author":"Erdinest","year":"2022","journal-title":"Cont Lens Anterior Eye."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0257480","DOI":"10.1371\/journal.pone.0257480","article-title":"Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine","volume":"16","author":"Yum","year":"2021","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.clae.2018.10.026","article-title":"Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-a preliminary retrospective study","volume":"42","author":"Chen","year":"2019","journal-title":"Cont Lens Anterior Eye."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.ophtha.2021.04.001","article-title":"COVID-19 quarantine reveals that behavioral changes have an effect on myopia progression","volume":"128","author":"Xu","year":"2021","journal-title":"Ophthalmology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"646770","DOI":"10.3389\/fpubh.2021.646770","article-title":"Survey on the progression of myopia in children and adolescents in Chongqing during COVID-19 pandemic","volume":"9","author":"Wang","year":"2021","journal-title":"Front Public Heal."},{"key":"B22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ophtha.2021.08.013","article-title":"Prevalence trend of myopia after promoting eye care in preschoolers: a serial survey in Taiwan before and during the coronavirus disease 2019 pandemic","volume":"129","author":"Yang","year":"2022","journal-title":"Ophthalmology."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15235.","article-title":"Myopia progression after cessation of low-dose atropine eyedrops treatment: a two-year randomized, double-masked, placebo-controlled, cross-over trial","author":"Wei","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3390\/jcm9082371","article-title":"The combined effect of low-dose atropine with orthokeratology in pediatric myopia control: review of the current treatment status for myopia","volume":"9","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/jcm7090259","article-title":"The synergistic effects of orthokeratology and atropine in slowing the progression of myopia","volume":"7","author":"Wan","year":"2018","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/02713683.2019.1568501","article-title":"Combined atropine with orthokeratology for myopia control: study design and preliminary results","volume":"44","author":"Tan","year":"2019","journal-title":"Curr Eye Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/bjophthalmol-2020-317664","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study","volume":"106","author":"Lam","year":"2022","journal-title":"Br J Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2143781","DOI":"10.1001\/jamanetworkopen.2021.43781","article-title":"Evaluation of an optical defocus treatment for myopia progression among schoolchildren during the COVID-19 pandemic","volume":"5","author":"Choi","year":"2022","journal-title":"JAMA Netw open."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1186\/s12889-020-09429-3","article-title":"Early effects of the COVID-19 pandemic on physical activity and sedentary behavior in children living in the U.S","volume":"20","author":"Dunton","year":"2020","journal-title":"BMC Public Health."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1074272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T07:49:40Z","timestamp":1674719380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1074272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2023.1074272"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1074272","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"article-number":"1074272"}}